Nationwide Implementation of Standardized Structured Reporting
IMPROVING
2 other identifiers
observational
50
1 country
1
Brief Summary
The first objective is to explore factors that impede or facilitate implementation of SSR in pathology (and other disciplines) among the MDT members receiving SSRs. The second objective is to select, develop and evaluate (process and effect outcomes) implementation tools supporting optimal implementation of SSR in pathology. The third objective is to offer implementation tools to all pathology laboratories in the Netherlands and to share the SSR-kit for successful implementation with other medical disciplines
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Aug 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 14, 2018
CompletedStudy Start
First participant enrolled
August 21, 2018
CompletedFirst Posted
Study publicly available on registry
August 28, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2020
CompletedAugust 28, 2018
August 1, 2018
1.9 years
August 14, 2018
August 27, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Barriers and facilitators in implementation of SSR in MDT - focus groups and self-developed questionnaire
Barriers and facilitators in implementation of SSR among MDT members measured by focus groups and a self-developed questionnaire
9 months
Effectiveness of implementation tools - frequencies of use of SSR templates in pathology in the Netherlands
The improvement in use of SSR templates in the Netherlands (=effectiveness of implementation tools) measured by frequencies of use of SSR templates in pathology (=all laboratories in the Netherlands)
6 months
Secondary Outcomes (3)
Determinants of barriers and facilitators in implementation of SSR - focus groups and a self-developed questionnaire
1 month
Experiences with implementation tools - questionnaire
6 months
Use of implementation tools - questionnaire
6 months
Study Arms (6)
Dutch pathologists hospital I
Pathologists in hospital I using protocols of: Urological cancer Gynaecological cancer Gastro intestinal cancer
Dutch pathologists hospital II
Pathologists in hospital II using protocols of: Urological cancer Gynaecological cancer Gastro intestinal cancer
Dutch pathologists hospital III
Pathologists in hospital III using protocols of: Urological cancer Gynaecological cancer Gastro intestinal cancer
Dutch pathologists hospital IV
Pathologists in hospital IV using protocols of: Urological cancer Gynaecological cancer Gastro intestinal cancer
Dutch pathologists hospital V
Pathologists in hospital V using protocols of: Urological cancer Gynaecological cancer Gastro intestinal cancer
Dutch pathologists hospital VI
Pathologists in hospital VI using protocols of: Urological cancer Gynaecological cancer Gastro intestinal cancer
Interventions
Implementation tools developed by experts in order to increase the use of SSR in pathology
Eligibility Criteria
Dutch pathologists, MDT-members and residents, using SSR of urological, gynecological or gastro-intestinal cancers.
You may qualify if:
- Pathologists of urological, gynecological or gastro-intestinal cancers
- Other MDT-members of urological, gynecological or gastro-intestinal cancers (medical oncologists, radiologists, radiotherapists, urologists, gynecologists, intestinal surgeons, nuclear medicine physicians, nurse practitioners).
- Dutch
- Residents
You may not qualify if:
- Retirees
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Radboud University Medical Centerlead
- Dutch Cancer Societycollaborator
- PALGA foundationcollaborator
Study Sites (1)
Radboud University Nijmegen Medical Center
Nijmegen, Gelderland, 6525GA, Netherlands
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- dr.
Study Record Dates
First Submitted
August 14, 2018
First Posted
August 28, 2018
Study Start
August 21, 2018
Primary Completion
June 30, 2020
Study Completion
June 30, 2020
Last Updated
August 28, 2018
Record last verified: 2018-08